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Abstract
Computational methods for image-based profiling are under active development, but their success hinges on assays
that can capture a wide range of phenotypes. We have developed a multiplex cytological profiling assay that “paints
the cell” with as many fluorescent markers as possible without compromising our ability to extract rich, quantitative
profiles  in  high  throughput.  The  assay  detects  seven  major  cellular  components.  In  a  pilot  screen  of  bioactive
compounds, the assay detected a range of cellular phenotypes and it clustered compounds with similar  annotated
protein targets or chemical structure based on cytological profiles. The results demonstrate that the assay captures
subtle patterns in the combination of morphological labels, thereby detecting the effects of chemical compounds even
though their targets are not stained directly. This image-based assay provides an unbiased approach to characterize
compound- and disease-associated cell states to support future probe discovery.
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Introduction
Gene-expression  profiling,  the  most  established  unbiased
profiling  method,  has  been  used  to  support  small-molecule
discovery in number of ways. For example, gene expression
has been used to define disease states, such as those caused
by  genomic  alterations  in  cancer,  thereby  enabling
identification of compounds that reverse the cellular phenotype
to a preferable state [1]. Gene expression has also been used
to  infer  compound  mechanism  of  action  by  revealing  that
previously  unconnected  compounds  yield  similar  profiles  in
cells,  or  by  revealing  that  sets  of  genes  enriched  for  those
having specific functions are regulated in a concerted manner
[2,3]. Microscopy images of cells are increasingly being used
for  profiling  [4,5]  because  they  contain  a  large  amount  of
quantitative  information  about  a  wide  range  of  complex
phenotypes, and because image-based assays can be scaled
to medium and high throughput with relative ease. It has for
some time been possible to measure hundreds of properties of
individual cells in microscopy images [6] and to find nonlinear
combinations of features that can identify complex phenotypes
[7]. Computational methods for image-based profiling are under
active  development  [8-13],  but  have  largely  been  applied  to
assays  that  model  particular  phenotypes  of  interest  with
minimal numbers of labels. Applying these methods in a more
unbiased manner to, for example, discover new phenotypes of
interest, requires development of an assay that can capture a
much wider range of phenotypes.
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We sought to develop an assay that “paints the cell” with as
many  fluorescent  morphological  labels  as  possible  without
compromising  our  ability  to  extract  quantitative  image-based
profiles in high throughput. We present a multiplex cytological
profiling  assay  that  allows  detection  of  seven  major  cell
components  (Figure  1A),  and  we  demonstrate  its  ability  to
capture a wide range of cellular phenotypes induced by small
molecules (Figure 1B). Further, we demonstrate the ability of
the  profiling  data  to  connect  compounds  with  similar
mechanisms of action (Figure 2). Because the profiles capture
subtle patterns in the combination of morphological labels, the
assay  can  detect  the  effects  of  chemical  compounds  even
though their targets are not stained directly.
We  considered  only  well-characterized,  fluorescent,  non-
antibody dyes suitable for high-throughput application. We first
screened a number of potential dyes for those with high signal,
low  background,  assay  buffer  compatibility,  fixation  and
permeabilization  condition  compatibility,  staining  time,  and
optical  spectra.  To  ensure  compatibility  with  commonly
available  microscopes,  we  limited  the  protocol  to  detecting
stains in five channels. Within that constraint, we increased the
degree of multiplexing by including two dyes for a given optimal
spectrum if they stained spatially distinct cellular components
that  could  be  distinguished  during  analysis.  The  staining
protocol  was  optimized  largely  based  on  qualitative
assessment of cellular features of interest. Particular attention
was paid to the relative concentration of WGA and phalloidin to
allow  visualization  of  the  Golgi  apparatus,  but  not  at  the
expense  of  detection  of  actin  filaments.  Pilot  plates  were
assayed  with  varying  concentrations  of  WGA  and  phalloidin.
Images  were  examined  by  eye  to  select  the  optimal
concentrations.
The final protocol involves imaging five channels to detect
seven cell components using six stains (Table 1, Figure 1A),
which were significantly optimized for dye concentration, buffer
composition, staining time, and permeabilization, blocking, and
washing  conditions.  The  protocol  is  readily  transferable  to
multiple adherent cell lines (Figure S1).
We  validated  the  assay  by  profiling  1600  commercially
available bioactive compounds (Table S1) spanning a range of
mechanisms  of  action.  Briefly,  U2OS  cells  were  plated  in
quadruplicate  in  384-well  plates,  incubated  for  24  h  to  allow
cells  to  adhere  and  resume  growth,  and  then  treated  with
compounds for 48 h (typical concentration 10 µM). Following
the  multiplex  cytological  profiling  protocol,  images  were
captured at 20x magnification with an automated epifluorescent
microscope. We extracted 824 morphological features (Table
S2) from each cell using the open-source software CellProfiler
[6]. A number of cellular phenotypes could be detected by eye
(Figure 1B). The profiles of the 64 mock-treated wells on each
plate vary little over the course of the experiment (Figure S2,
Table S3), although some positional effects are evident (Figure
S3, Table S4). Roughly half of the features showed significant
response to one or more compounds (Figure S4). The group of
Figure 1.  The cell-painting assay applied to U2OS cells.  (A) Cells labeled with Hoechst 33342 (nuclei, blue), concanavalin A
(ER), SYTO 14 (nucleoli), phalloidin (actin), WGA (Golgi), MitoTracker Deep Red (mitochondria). Scale bars 50 µm. (B) Ten diverse
phenotypes in compound-treated U2OS cells: toroid nuclei (amperozide); giant, multinucleated cells (fenbendazole); abundant ER
(tetrandrine); redistribution of ER to one side of nucleus (NPPB); reduced nucleolar size (rapamycin); large, flat nucleoli (etoposide);
bright, abundant Golgi staining (Ca-074-Me); actin breaks (latrunculin B); extensive mitochondrial fission (Beta-dihydrorotenone);
and redistribution of mitochondria (berberine chloride). Scale bars 50 μm.
doi: 10.1371/journal.pone.0080999.g001
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PLOS ONE | www.plosone.org 2 December 2013 | Volume 8 | Issue 12 | e80999Figure 2.  Hierarchical clustering of image-based profiles.  Details are shown for three of the clusters that were highly enriched
for annotation terms. These enriched clusters contain compounds with similar mechanisms of action, some with similar and some
with distinct chemical structure. The presence of these enriched clusters indicates that the assay can identify subtle, physiologically
relevant effects of compounds on cultured cells. U2OS cells labeled for nuclei (blue), ER (green), nucleoli (grey), actin and Golgi
(yellow), and mitochondria (red). Scale bars 50 µm.
doi: 10.1371/journal.pone.0080999.g002
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Zernike shape features (Table S5).
To determine whether image-based profiles derived from the
multiplex assay are useful for studying compound mechanism-
of-action,  we  examined  whether  clustering  compounds
according  to  image-based  profile  similarity  would  group
compounds with similar annotated protein targets or chemical
structure.  After  clustering  hierarchically  the  75  active
compounds  for  which  we  had  annotations  and  ranking  the
clusters' enrichment of annotation terms, we found that several
of  the  most  enriched  clusters  were  convincing  mechanistic
groups  (Figure  2).  For  example,  cluster  A  contains  both
structurally  related  and  distinct  modulators  of  tubulin
(fenbendazole;  oxibendazole;  taxol),  which  lead  to  large
multinucleated  cells  with  fused  nucleoli.  The  promotion  of
polyploidization and multinucleation by tubulin modulators has
been long recognized [14,15]. Cluster B contains modulators of
neuronal  receptors,  all  of  which  lead  to  enhanced  Golgi
staining and some cells with fused nucleoli: fluphenazine (D1
and  D2  dopamine  receptor  antagonist),  metoclopramide  (D2
dopamine  antagonist;  muscarinic  M1  receptor  antagonist;  5-
hydroxytramine  4  receptor  agonist),  as  well  as  procaine
(sodium  channel  antagonist),  a  structural  analog  of
metaclopramide  (DrugBank  [16]  acc.  DB01233).  It  is  worth
noting that all three compounds contain a basic tertiary amine,
which  has  been  linked  to  compound  accumulation  in  acidic
cellular compartments, such as the lysosome and Golgi, with
effects on their shape and function [17]. It is possible that this
chemical feature and cellular mechanism underlie the shared
effect of these compounds on morphology rather than channel
inhibition. Cluster C contains a number of structurally related
cardenolide  glycosides  (digoxin;  lanatoside  C;  peruvoside;
neriifolin;  digitoxin),  characterized  by  reduced  cell  size,
condensed  nuclei,  plasma  membrane  blebbing,  reduced
nucleolar staining, and significant cytotoxicity (Text S2). While
compounds  of  this  class  are  thought  to  affect  a  range  of
biological  processes,  their  effects  on  morphology  are
consistent with their reported ability to cause cell death [18,19].
Discussion
A rich multiplex assay, such as our cell-painting assay, is a
necessary step towards productively profiling a large collection
of small molecules. Profiles from such an experiment could be
mined to identify regulators of dozens of different phenotypes
without having to design and optimize specific assays for each
phenotype.  Rather,  a  large,  unbiased  profiling  experiment
could be performed once and then efficiently and inexpensively
mined  for  multiple  patterns,  including  unexpected  patterns
associated with a perturbation of interest. The rich patterns in
the profiles could also be used to group small molecules based
on  their  similarity  to  generate  hypotheses  about  which  small
molecules share a common mechanisms of action.
Cellular morphology is affected by a number of factors, such
as  the  genetic  and  epigenetic  state  of  the  cell,  physiologic
processes such as cell division or metabolism, and changes in
environmental  cues  that  alter  cell  signaling.  Extensive
measurement of morphological features, treated as a profile,
can  be  applied  to  study  the  response  of  cells  to  diverse
perturbations or to characterize the differences between cells
from  disease  and  non-disease  states.  The  multiplex  assay
described here increases the number of morphological features
that  can  be  quantified  by  microscopy  and  image  analysis  to
create image-based profiles. We anticipate the assay will be
useful for characterizing perturbations whose effects are poorly
understood,  such  as  novel  small  molecules  or  disease-
associated  variants  emerging  in  genome-wide  association
studies.  We  provide  the  complete  set  of  images  from  our
experiment as well as source code for computer programs that
reproduce our results (Text S1).
Materials and Methods
Plating
U2OS cells (#HTB-96, ATCC) were plated at the density of
1500–2000 cells per well in 384-well imager quality black/clear
plates  (Aurora  Biotechnologies/Nexus  Biosystems)  in  50  µL
DMEM  supplemented  with  10%  fetal  bovine  serum,  and  1%
penicillin/streptomycin. Cells were grown for 24 h at 37°C.
Compound Pinning
Compounds were pin-transferred to cells using a CyBi-Well
robot (CyBio, Inc.). Cells were treated for 48 h at 37°C.
Staining
The samples were stained as follows.
Step  1:  MitoTracker  and  Wheat  Germ  Agglutinin
staining.  MitoTracker Deep Red (#M22426, Invitrogen) was
dissolved in DMSO to 1 mM. Wheat Germ Agglutinin (WGA)
Alexa594  conjugate  (#W11262,  Invitrogen)  was  dissolved  in
dH2O  to  1  mg/mL.  A  500  nM  MitoTracker,  60  µg/mL  WGA
Table 1. Multiplex cytological profiling assay components.
Cellular component(s) Stain Detection (ex/em)
nucleus Hoechst 33342 387/447 nm
endoplasmic reticulum concanavalin A (con A) AlexaFluor488 conjugate 472/520 nm
nucleoli SYTO 14 green fluorescent nucleic acid stain 531/593 nm
Golgi apparatus and plasma membrane wheat germ agglutinin (WGA) AlexaFluor594 conjugate 562/642 nm
F-actin phalloidin AlexaFluor594 conjugate 562/642 nm
mitochondria MitoTracker Deep Red 628/692 nm
doi: 10.1371/journal.pone.0080999.t001
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1%  penicillin/streptomycin).  Media  was  removed  from  plates;
residual  volume  was  10  µL  in  each  well.  30  µL  of  staining
solution was added to wells and incubated for 30 min at 37 °C.
Step  2:  Fixation.    10  µL  of  16%  methanol-free
paraformaldehyde  (#15710-S,  Electron  Microscopy  Services)
was added to wells for a final concentration of 3.2%. The plates
were  then  incubated  at  room  temperature  for  20  min.  Wells
were  washed  once  with  70  µL  1xHBSS  (#14065-056,
Invitrogen).
Step 3: Permeabilization.  A 0.1% solution of Triton X-100
(T8787-100mL, Sigma) was prepared in 1x HBSS. 30 µL of the
solution was added to the wells and incubated for 10–20 min.
Wells were washed twice with 70 µL 1x HBSS.
Step 4: Phalloidin, ConcanavalinA, Hoechst, and SYTO
14 staining.  Concanavalin A Alexa488 conjugate (#C11252,
Invitrogen)  was  dissolved  to  1  mg/mL  in  0.1  M  sodium
bicarbonate (SH30033.01, HyClone), and Phalloidin Alexa594
conjugate  (#A12381,  Invitrogen)  was  dissolved  in  1.5  mL
methanol  (67-56-1,  BDH)  per  vial.  A  0.025  µL  phalloidin/µL
solution,  100  µg/mL  ConcanavalinA,  5  µg/mL  Hoechst33342
(#H3570,  Invitrogen),  and  3  µM  SYTO14  green  fluorescent
nucleic acid stain (#S7576, Invitrogen) solution was prepared in
1x HBSS, 1% BSA. 30 µL of staining solution was added to
wells and incubated for 30 min. Wells were washed three times
with 70 µL 1xHBSS, no final aspiration. Plates were sealed with
blue Remp thermal seal, at 171 °C for 4 s.
Imaging
Images were captured at 20x magnification in 5 fluorescent
channels,  DAPI  (387/447  nm),  GFP  (472/520  nm),  Cy3
(531/593 nm), TexasRed (562/642 nm), Cy5 (628/692 nm) on
an  ImageXpress  Micro  epifluorescent  microscope  (Molecular
Devices), 9 sites per well, with laser based autofocus in the
DAPI channel, first site of each well.
Image analysis
Version 2.0.9925 of the image-analysis software CellProfiler
[6]  was  used  to  locate  and  segment  the  cells  and  measure
many  features  of  each  cell  (Table  S2)  using  the  pipelines
provided (Text S1). After correcting for uneven illumination, the
pipeline identifies the nuclei from the DAPI channel and uses
the nuclei as seeds to help a segmentation algorithm identify
the  cytoplasm[20,21].  The  pipeline  measure  size,  shape,
texture,  intensity  statistics,  and  local  density  of  the  nuclei,
cytoplasms, and entire cells.
Annotation
We  used  annotations  that  have  previously  been  collected
and curated over the course of several projects. Many of the
annotations have been deposited into ChemBank [22], but the
annotation work has continued after ChemBank became static.
The annotations we used are included as supplementary data.
The annotations covered 649 of the 1600 compounds in the
experiment (Table S6). Some annotations were from the Gene
Ontology  [23]  (including  GOMF,  GOBP,  and  GOCC).  Others
were  medical  subject  headings  (MeSH)  or  product  use/class
fields from the compounds’ material safety data sheets. There
were also a small number of protein targets (Entrez GeneIDs)
among the annotations.
The  annotation  terms  had  been  “slimmed,”  replacing
excessively detailed terms with more general terms that give a
broader  overview.  The  GO  annotations  were  slimmed  using
GO  slim  [23],  whereas  MeSH  and  product  use/class  terms
were slimmed by manual inspection. The protein targets were
slimmed  by  assigning  the  appropriate  GOMF,  then  applying
GO slim.
Finding term-enriched clusters
We  identified  clusters  and  scored  them  for  enrichment  for
annotation terms as follows.
1 Computed a profile for each of the 7680 samples (20 plates
with  384  wells  per  plate)  by  averaging  each  CellProfiler-
generated feature across the cells in the well. Averaging has
been  effective  for  profiling  even  though  it  does  not  explicitly
model heterogeneity among cells [4,10]. The entire CellProfiler
feature set was used for the analysis; while feature reduction
techniques  may  result  in  incremental  improvements  in
performance,  we  chose  to  transform  the  data  as  little  as
possible  in  order  to  focus  the  evaluation  on  the  assay  itself
rather  than  advanced  data-analysis  methods.  For  the  same
reason, we also chose well-known and transparent methods for
the subsequent steps of the analysis.
2 Aggregated  the  7680  per-sample  profiles  into  1601  per-
compound profiles by computing the element-wise median. The
1601 per-compound profiles include the median mock profile,
i.e., the median profile of all DMSO-treated samples.
3 Excluded  compounds  that  were  inactive  in  the  assay.
Compounds  were  deemed  to  be  active  if  their  profiles’
Euclidean  distance  to  the  median  mock  profile  was  above  a
cutoff. The cutoff was the 95th percentile of the distances from
the mock-treated wells to the median mock profile. Of the 1600
compounds, 203 (13%) were active.
4 Excluded  compounds  that  were  unannotated.  Of  the  203
active compounds, 75 were annotated by one or more of 96
slimmed terms (Table S7).
5 Performed hierarchical clustering of the compound profiles of
the 75 compounds that were active and annotated, using the
cosine distance and single linkage.
6 Assessed whether each possible cluster is enriched by each
annotation term (Table S8). There were 74 possible clusters,
one for each non-leaf subtree of the dendrogram produced by
the  hierarchical  clustering.  The  assessment  was  by
permutation  testing:  we  measured  the  fraction  of  random
clusters of the same size that had at least the same number of
compounds  annotated  with  the  term  in  question.  When
constructing  random  clusters  for  permutation  testing,  the
cluster members were drawn from a uniform distribution over
the  compounds.  It  was  not  necessary  to  correct  for  multiple
testing because the fractions were only used for ranking and
not interpreted as p-values. Enrichment in GO terms has also
recently  been  used  to  validate  clusters  of  profiles  generated
from  HTS  experiments  [24].  Table  S8  shows  the  clusters
ranked  by  permutation-testing  score,  i.e.,  the  fraction  of
random  clusters  that  had  at  least  the  same  number  of
compounds  annotated  with  the  term  in  question.  For  each
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number of times the enriched term occurs in the cluster, and
the  number  of  times  the  enriched  term  occurs  in  the  entire
dataset.  For  each  compound  in  the  cluster,  the  table  shows
whether the compound has the enriched term, as well as the
compound’s  name  and  Broad  ID  (internal  identifier  from  our
compound-management department).
Reproducibility
We  provide  (Text  S1)  the  complete  image  set,  the
CellProfiler  pipelines  used  to  identify  and  measure  the  cells,
the database of cellular features, and the source code for the
programs  that  analyze  the  features  and  produce  the  figures
and tables in this article.
Supporting Information
Dataset S1.  CellProfiler pipelines.
(ZIP)
Dataset S2.  CellProfiler illumination function.
(ZIP)
Dataset S3.  Image features extracted by CellProfiler.
(DOCX)
Dataset S4.  Source code to programs that analyze image
features.
(ZIP)
Figure  S1.    The  cell-painting  protocol  was  developed  on
U2OS  cells,  but  it  is  readily  transferable  to  multiple
adherent  cell  lines,  viz.  3T3  fibroblasts,  A549
adenocarcinomic  human  alveolar  basal  epithelial  cells,
HTB-9  human  bladder  carcinoma  cell,  and  MCF-7  breast
cancer cells.
Scale bars 50 µm.
(TIF)
Figure S2.  The plate-to-plate variability in the experiment
is small (< 0.2) for the vast majority of features.
The histogram shows the distribution of coefficients of variation
(absolute  value)  across  the  features.  Each  coefficient  was
computed across 12 values of the relevant feature: the average
across the mock-treated cells on each of the 12 plates in the
experiment.
(PDF)
Figure S3.  The well-to-well variability in the experiment is
small (< 0.2) for the vast majority of features.
The histogram shows the distribution of coefficients of variation
(absolute  value)  across  the  features.  Each  coefficient  was
computed across the 64 well positions in which mock-treated
cells appear on each plate in the experiment.
(PDF)
Figure S4.  The magnitude of the compounds’ effects on
the features. The histogram shows the distribution of maximal
values of the features across the 75 active compounds in the
experiment,  standardized  by  reference  to  the  population  of
mock-treated cells on the same plate.
(PDF)
Table S1.  The 1600 bioactive compounds profiled using
our assay.
(DOCX)
Table  S2.    Image  features  measured  for  each  cell  by
CellProfiler (see the CellProfiler manual for descriptions of
each feature).
(DOC)
Table S3.  Features ranked by plate-to-plate coefficient of
variation (absolute), limited to mock-treated cells.
(DOCX)
Table  S4.    Features  ranked  by  well-to-well  coefficient  of
variation (absolute), limited to mock-treated cells.
(DOCX)
Table S5.  Features ranked by maximal value across the
compounds.
(DOCX)
Table S6.  Compounds that were annotated.
(DOCX)
Table  S7.    The  compounds  that  were  both  active  and
annotated.
(DOCX)
Table  S8.    The  clusters  of  compounds  most  highly
enriched for annotation terms.
(DOCX)
Text S1.  Data and software.
(DOCX)
Text S2.  Cytotoxicity.
(DOC)
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